Diacomit(Stiripentol) Side Effects

Common adverse reactions (≥10% incidence) include somnolence, decreased appetite, ataxia, weight loss, hypotonia, nausea, tremor, and insomnia.  

Frequent and Serious Adverse Events  

In clinical trials, somnolence (67%), appetite loss (45%), agitation (27%), ataxia (27%), and weight loss (27%) were predominant. Serious risks include neutropenia (13%), thrombocytopenia (13%), and suicidality (class-wide AED warning). Gastrointestinal effects (nausea, vomiting) and neurologic symptoms (dysarthria, tremor) are notable. Rare events include aggression and salivary hypersecretion. Long-term data show similar safety profiles in infants ≥6 months. Overdose management is supportive; no antidote exists. Drug interactions (e.g., elevated clobazam/norclobazam levels) require vigilant monitoring.

Stiripentol(Diacomit)
Stiripentol is indicated for the treatment of seizures associated with Dravet syndrome (severe myoclonic epilepsy in infants) in patients aged 6 months and older, weighing 7 kg or...
RELATED ARTICLES
Onset time of stiripentol

The onset time of stiripentol has always been the focus of patients and their families. Due to the influence of...

Thursday, July 3rd, 2025, 15:11
/ 1
1 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved